Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Antimicrob Agents Chemother
1 Chest
1 Clin Infect Dis
12 Int J Tuberc Lung Dis
6 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. YAMADA W, Kim S, Almoslem M, Kim S, et al
    Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype.
    Antimicrob Agents Chemother. 2022 Sep 27:e0069522. doi: 10.1128/aac.00695.
    PubMed         Abstract available


  2. VASSALL A, Masiye F
    Replenishing the Global Fund to Fight AIDS, Tuberculosis, and Malaria.
    BMJ. 2022;378:o2320.


  3. DESHMUKH S, Sane M, Gaikwad S, Sahasrabudhe T, et al
    Sex differences in tuberculosis clinical presentation, drug exposure, and treatment outcomes in India.
    Chest. 2022 Sep 26. pii: S0012-3692(22)03893-4. doi: 10.1016/j.chest.2022.
    PubMed         Abstract available

    Clin Infect Dis

  4. EOM JS, Park S, Jang H, Kim S, et al
    Bronchial washing using a thin versus a thick bronchoscope to diagnose pulmonary tuberculosis: A randomized trial.
    Clin Infect Dis. 2022 Sep 24. pii: 6713550. doi: 10.1093.
    PubMed         Abstract available

    Int J Tuberc Lung Dis

  5. MANGOCHI P, Bossard C, Catacutan C, Van Laeken D, et al
    TB screening, prevention and treatment cascade in a Malawi prison.
    Int J Tuberc Lung Dis. 2022;26:956-962.
    PubMed         Abstract available

  6. FATIMA R, Yaqoob A, Qadeer E, Khan MA, et al
    Community- vs. hospital-based management of multidrug-resistant TB in Pakistan.
    Int J Tuberc Lung Dis. 2022;26:929-933.
    PubMed         Abstract available

  7. SCHWALB A, Emery JC, Houben RMGJ
    Use of chest radiography screening for TB: a re-evaluation of the Kolin study.
    Int J Tuberc Lung Dis. 2022;26:983-985.

  8. ROUZIER V, Murrill M, Kim S, Naini L, et al
    Caregiver willingness to give TPT to children living with drug-resistant TB patients.
    Int J Tuberc Lung Dis. 2022;26:949-955.
    PubMed         Abstract available

  9. DIALLO A, Combary A, Bakyono R, Guene H, et al
    A 2020 baseline assessment for the monitoring of the End TB indicator of catastrophic costs in Burkina Faso.
    Int J Tuberc Lung Dis. 2022;26:970-977.
    PubMed         Abstract available

  10. PORRETTA AD, Manga S, Pontali E
    TB care in prisons: the ongoing challenge.
    Int J Tuberc Lung Dis. 2022;26:906-907.

  11. BLACKBOURN H, Tiberi S, Felker I
    Literature Highlights.
    Int J Tuberc Lung Dis. 2022;26:914-916.
    PubMed         Abstract available

  12. CATES L, Codreanu A, Ciobanu N, Fosburgh H, et al
    Budget impact of next-generation sequencing for diagnosis of TB drug resistance in Moldova.
    Int J Tuberc Lung Dis. 2022;26:963-969.
    PubMed         Abstract available

  13. MENEZES D, Zenner D, Aldridge R, Anderson SR, et al
    Country differences and determinants of yield in programmatic migrant TB screening in four European countries.
    Int J Tuberc Lung Dis. 2022;26:942-948.
    PubMed         Abstract available

  14. TYEKU N, Apolisi I, Daniels J, Beko B, et al
    Pediatric delamanid treatment for children with rifampicin-resistant TB.
    Int J Tuberc Lung Dis. 2022;26:986-988.

  15. MARAIS BJ, Bernays S, Schaaf HS, Fox GJ, et al
    Increasing TB preventive treatment in children.
    Int J Tuberc Lung Dis. 2022;26:903-905.

  16. AIA P, Viney K, Kal M, Kisomb J, et al
    The economic burden of TB faced by patients and affected families in Papua New Guinea.
    Int J Tuberc Lung Dis. 2022;26:934-941.
    PubMed         Abstract available

    PLoS One

  17. CANTERA JL, Lillis LM, Peck RB, Moreau E, et al
    Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.
    PLoS One. 2022;17:e0274415.
    PubMed         Abstract available

  18. ARIF S, Akhter M, Khaliq A, Akhtar MW, et al
    Fusion peptide constructs from antigens of M. tuberculosis producing high T-cell mediated immune response.
    PLoS One. 2022;17:e0271126.
    PubMed         Abstract available

  19. SCRIVO R, Molteni E, Castellani C, Altobelli A, et al
    Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
    PLoS One. 2022;17:e0275329.
    PubMed         Abstract available

  20. HERRERA M, Keynan Y, McLaren PJ, Isaza JP, et al
    Gene expression profiling identifies candidate biomarkers for new latent tuberculosis infections. A cohort study.
    PLoS One. 2022;17:e0274257.
    PubMed         Abstract available

  21. GOMES I, Dong C, Vandewalle P, Khan A, et al
    Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects.
    PLoS One. 2022;17:e0270816.
    PubMed         Abstract available

  22. ALEMAYEHU A, Kebede A, Neway S, Tesfaye E, et al
    A glimpse into the genotype and clinical importance of non tuberculous mycobacteria among pulmonary tuberculosis patients: The case of Ethiopia.
    PLoS One. 2022;17:e0275159.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  23. CROWE AM, Krekhno JMC, Brown KL, Kulkarni JA, et al
    The unusual convergence of steroid catabolic pathways in Mycobacterium abscessus.
    Proc Natl Acad Sci U S A. 2022;119:e2207505119.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.